Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Expanded access trial of maraviroc in treatment-experienced HIV-1 patients
2006-004306-50Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of maraviroc in human immunodeficiency virus infection (HIV) and Human immunodeficiency virus infection type 1, sponsored by Pfizer. Primary endpoint: Safety. Started Mar 2007; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2006-004306-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004306-50.